TLR4 mutations (Asp299Gly and Thr399Ile) are not associated with ankylosing spondylitis

Annals of the Rheumatic Diseases

Volumn 65, Issue 8, 2006, Pages 1099-1101

  Adam, R ^a   Sturrock, R D ^b   Gracie, J A ^b  

^a NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; HLA B27 ANTIGEN; ISOLEUCINE; THREONINE; TOLL LIKE RECEPTOR 4;

ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE MUTATION; GENOTYPE; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL ANALYSIS;

CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-B27 ANTIGEN; HUMANS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; SAMPLE SIZE; SPONDYLITIS, ANKYLOSING; TOLL-LIKE RECEPTOR 4;

EID: 33746579762     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.045476     Document Type: Article

References (14)

1. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000;25:187-91.
2. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002;347:185-92.
3. Hausmann M, Kiessling S, Mestermann S, Webb G, Spottl T, Andus T, et al. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 2002;122:1987-2000.
4. Mielants H, Veys EM, Goemaere S, Goethals K, Cuvelier C, De Vos M. Gut inflammation in the spondylarthropathies: clinical, radiological, biological and genetic features in relation to the type of histology. A prospective study. J Rheumatol 1991;18:1542-51.
5. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
6. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, et al. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004;53:987-92.
7. Torok HP, Glas J, Tonenchi L, Mussack T, Folwaczny C. Polymorphisms of the lipopolysaccharide-signalling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clin Immunol 2004;112:85-91.
8. Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002;123:86-91.
9. Obana N, Takahashi S, Kinouchi Y, Negoro K, Takagi S, Hiwatashi N, et al. Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14. Scand J Gastroenterol 2002;37:699-704.
10. Klein W, Tromm A, Griga T, Fricke H, Folwaczny C, Hocke M, et al. A polymorphism in the CD14 gene is associated with Crohn disease. Scand J Gastroenterol 2002;37:189-91.
11. van der Paardt M, Crusius JB, de Koning MH, Morre SA, van de Stadt RJ, Dijkmans BA, et al. No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis. Ann Rheum Dis 2005;64:235-8.
12. Bennett PH, Burch TA. Population studies of rheumatic diseases. Excerpta Medica International Congress Series, Amsterdam 1968;148:456-7.
13. Raby BA, Klimecki WT, Laprise C, Renaud Y, Faith J, Lemire M, et al. Polymorphisms in Toll-like Receptor 4 are not associated with asthma or atopy-related phenotypes. Am J Respir Crit Care Med 2002;66:1449-56.
14. Read RC, Pullin J, Gregory S, Borrow R, Kaczmarski EB, di Giovine FS, et al. A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J Infect Dis 2001;184:640-2.